Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine

Jackie M Helms1 The Bleeding and Clotting Disorders Institute, Peoria, IL, USA

https://orcid.org/0000-0002-9466-7548

Kristin T Ansteatt1 The Bleeding and Clotting Disorders Institute, Peoria, IL, USA

https://orcid.org/0000-0001-8004-297X

Jonathan C Roberts1 The Bleeding and Clotting Disorders Institute, Peoria, IL, USA;2 Department of Medicine, University of Illinois College of Medicine-Peoria, Peoria, IL, USA

https://orcid.org/0000-0002-9415-9543

Sravani Kamatam3 Department of Medicine, Saint Francis Medical Center, Peoria, IL, USA

Kap Sum Foong2 Department of Medicine, University of Illinois College of Medicine-Peoria, Peoria, IL, USA;3 Department of Medicine, Saint Francis Medical Center, Peoria, IL, USA

https://orcid.org/0000-0001-6259-0032

Jo-mel S Labayog4 Department of Medicine, OSF Sacred Heart Medical Center, Danville, IL, USA

Michael D Tarantino1 The Bleeding and Clotting Disorders Institute, Peoria, IL, USA;2 Department of Medicine, University of Illinois College of Medicine-Peoria, Peoria, IL, USACorrespondence[email protected]

show all

Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date